Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQß1
  2. Valencia, Ana; Vergara, Candelaria; Thio, Chloe L; Vince, Nicolas; Douillard, Venceslas; Grifoni, Alba; Cox, Andrea L; Johnson, Eric O; Kral, Alex H; Goedert, James J; Mangia, Alessandra; Piazzolla, Valeria; Mehta, Shruti H; Kirk, Gregory D; Kim, Arthur Y; Lauer, Georg M; Chung, Raymond T; Price, Jennifer C; Khakoo, Salim I; Alric, Laurent; Cramp, Matthew E; Donfield, Sharyne M; Edlin, Brian R; Busch, Michael P; Alexander, Graeme; Rosen, Hugo R; Murphy, Edward L; Wojcik, Genevieve L; Carrington,Mary; Gourraud, Pierre-Antoine; Sette, Alessandro; Thomas, David L; Duggal, Priya
  3. American journal of human genetics. 2022, Jan 25; 109(2): 299-310.
  1. 2.   Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy
  2. Swanstrom,Adrienne; Immonen,Taina; Oswald,Kelli; Pyle,Cathi; Thomas,James; Bosche,Bj; Silipino,Lorna; Hull,Mike; Newman,Laura; Coalter, Vicky; Wiles,Adam; Wiles,Rodney; Kiser,Jacob; Morcock,David; Shoemaker,Rebecca; Fast,Randy; Breed,Matthew; Kramer,Josh; Donohue,Duncan; Malys,Tyler; Fennessey,Christine; Trubey,Charles; Deleage,Claire; Estes, Jacob D.; Lifson,Jeffrey; Keele,Brandon; Del Prete,Greg
  3. The Journal of Clinical Investigation. 2021, Mar 15; 131(6):
  1. 3.   Autophagy down regulates pro-inflammatory mediators in BV2 microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death
  2. Bussi, Claudio; Peralta Ramos, Javier Maria; Arroyo, Daniela S.; Gaviglio, Emilia A.; Ignacio Gallea, Jose; Wang, Jiming; Soledad Celej, Maria; Iribarren, Pablo
  3. SCIENTIFIC REPORTS. 2017, 2017-03-03; 7
  1. 4.   A Common HLA-DPA1 Variant is a Major Determinant of Hepatitis B Virus Clearance in Han Chinese
  2. An, P.; Winkler, C.; Guan, L.; O'Brien, S. J.; Zeng, Z.; Consortium, H. B. V. S.
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 943-947.
  1. 5.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 6.   Strong Influence of Human Leukocyte Antigen (HLA)-DP Gene Variants on Development of Persistent Chronic Hepatitis B Virus Carriers in the Han Chinese Population
  2. Guo, X. C.; Zhang, Y.; Li, J.; Ma, J. C.; Wei, Z. L.; Tan, W. J.; O'Brien, S. J.
  3. Hepatology. 2011, Feb; 53(2): 422-428.
  1. 7.   IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection
  2. Martin, M. P.; Qi, Y.; Goedert, J. J.; Hussain, S. K.; Kirk, G. D.; Hoots, W. K.; Buchbinder, S.; Carrington, M.; Thio, C. L.
  3. Journal of Infectious Diseases. 2010, Dec; 202(11): 1749-1753.
  1. 8.   Specific Human Leukocyte Antigen Class I and II Alleles Associated with Hepatitis C Virus Viremia
  2. Kuniholm, M. H.; Kovacs, A.; Gao, X. J.; Xue, X. N.; Marti, D.; Thio, C. L.; Peters, M. G.; Terrault, N. A.; Greenblatt, R. M.; Goedert, J. J.; Cohen, M. H.; Minkoff, H.; Gange, S. J.; Anastos, K.; Fazzari, M.; Harris, T. G.; Young, M. A.; Strickler, H. D.; Carrington, M.
  3. Hepatology. 2010, May; 51(5): 1514-1522.
  1. 9.   Minireview: Nanoparticles and the Immune System
  2. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
  3. Endocrinology. 2010, Feb; 151(2): 458-465.
  1. 10.   CD8+Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
  2. Klatt, N. R.; Shudo, E.; Ortiz, A. M.; Engram, J. C.; Paiardini, M.; Lawson, B.; Miller, M. D.; Else, J.; Pandrea, I.; Estes, J. D.; Apetrei, C.; Schmitz, J. E.; Ribeiro, R. M.; Perelson, A. S.; Silvestri, G.
  3. Plos Pathogens. 2010, Jan; 6(1): 11.
  1. 11.   Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance
  2. An, P.; Thio, C. L.; Kirk, G. D.; Donfield, S.; Goedert, J. J.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2008 198(8): 1159-1165.
  1. 12.   Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled A beta(42) peptide receptor, in microglial cells
  2. Chen, K. Q.; Zhang, L. Z.; Huang, J.; Gong, W. H.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Leukocyte Biology. 2008 83(6): 1467-1475.
  1. 13.   Contribution of CD8(+) T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in simian immunodeficiency virus-infected rhesus monkeys
  2. Kim, E. Y.; Veazey, R. S.; Zahn, R.; McEvers, K. J.; Baumeister, S.; Foster, G. J.; Rett, M. D.; Newberg, M. H.; Kuroda, M. J.; Rieber, E. P.; Piatak, M.; Lifson, J. D.; Letvin, N. L.; Wolinsky, S. M.; Schmitz, J. E.
  3. Journal of Virology. 2008 82(11): 5631-5635.
  1. 14.   Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV
  2. Mizukoshi, E.; Eisenbach, C.; Edlin, B. R.; Newton, K. P.; Raghuraman, S.; Weiler-Normann, C.; Tobler, L. H.; Busch, M. P.; Carrington, M.; McKeating, J. A.; O'Brien, T. R.; Rehermann, B.
  3. Journal of Infectious Diseases. 2008 198(2): 203-212.
  1. 15.   Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
  2. Neumann, A. U.; Polis, M. A.; Rozenberg, L.; Jackson, J. O.; Reitano, K. N.; McLaughlin, M.; Koratich, C.; Dewar, R. L.; Masur, H.; Haagmans, B. L.; Kottilil, S.
  3. Aids. 2007, Sep; 21(14): 1855-1865.
  1. 16.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 17.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 18.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 19.   Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance
  2. Oleksyk, T. K.; Thio, C. L.; Truelove, A. L.; Goedert, J. J.; Donfield, S. M.; Kirk, G. D.; Thomas, D. L.; O'Brien, S. J.; Smith, M. W.
  3. Genes and Immunity. 2005, JUN; 6(4): 347-357.
  1. 20.   Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release - Implications for Bordetella pertussis infections following aerosol challenge
  2. Carter, C. R. D.; Dagg, B. M.; Whitmore, K. M.; Keeble, J. R.; Asokanathan, C.; Rodgers, A.; Watanabe, M.; Xing, D.; Walker, K. B.
  3. Cytokine. 2005, MAY 7; 30(3): 100-108.
  1. 21.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 22.   p53 is a suppressor of inflammatory response in mice
  2. Komarova, E. A.; Krivokrysenko, V.; Wang, K. H.; Neznanov, N.; Chernov, M. V.; Komarov, P. G.; Brennan, M. L.; Golovkina, T. V.; Rokhlin, O.; Kuprash, D. V.; Nedospasov, S. A.; Hazen, S. R.; Feinstein, E.; Gudkov, A. V.
  3. Faseb Journal. 2005, APR; 19(6): Published online April 5, 2005.
  1. 23.   Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
  2. Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Sarafandi, A. A.; Sein, T.; Mickiene, D.; Bacher, J.; Groll, A. H.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2004, OCT; 48(10): 3959-3967.
  1. 24.   Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection
  2. Thio, C. L.; Mosbruger, T. L.; Kaslow, R. A.; Karp, C. L.; Strathdee, S. A.; Vlahov, D.; O'Brien, S. J.; Astemborski, J.; Thomas, D. L.
  3. Journal of Virology. 2004, OCT; 78(20): 11258-11262.
  1. 25.   MBL2 genotypes are important determinants of HBV clearance or persistence
  2. Thio, C. L.; Mosbruger, T.; Astemborski, J.; Greer, S.; Vlahov, D.; O'Brien, S.; Thomas, D.
  3. Hepatology. 2004, OCT; 40(4, Suppl. 1): 594A-595A.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel